Hovenia Dulcis: Traditional Use, History, and Why Modern Science Caught Up

DHM doesn’t come from a lab. It comes from a tree that’s been used in East Asian medicine for liver support and alcohol-related conditions for over a thousand years.

The science caught up eventually. Here’s the history.

Educational content. Not medical advice.

The Plant

Hovenia dulcis — commonly called the Japanese raisin tree or Oriental raisin tree — is a deciduous tree native to China, Japan, and Korea. It grows to 10–15 meters, produces small greenish-white flowers, and bears a distinctive fruit: small round berries attached to thickened, fleshy, and sweet-tasting peduncles (the stem structures), which are the part most commonly consumed.

The tree is cultivated across East Asia, with major production in China’s Sichuan, Yunnan, and Guizhou provinces. It’s not a commercial food crop in the Western sense — its primary historical use has been medicinal.

Traditional Chinese Medicine: The Record

The earliest documented medicinal use of Hovenia dulcis appears in the Tang Materia Medica (Tang Bencao, 659 AD) — the official pharmacopoeia of the Tang Dynasty, compiled by imperial order. The text describes the fruit and peduncles as useful for “counteracting the effects of alcohol” and for “liver and stomach conditions.”

Later texts in the Chinese materia medica tradition, including the Compendium of Materia Medica (Bencao Gangmu, 1596 AD) compiled by Li Shizhen — arguably the most comprehensive work in the history of Chinese medicine — describe Hovenia dulcis in detail:

“Relieves alcohol toxicity. Clears heat and promotes urination. Benefits the stomach.”

The “alcohol toxicity” framing in TCM overlaps with what modern biochemistry identifies as acetaldehyde accumulation and oxidative stress — the mechanisms DHM demonstrably addresses.

Japanese traditional medicine (Kampo) similarly documents Hovenia dulcis use. The dried peduncles (Hoveniae Semen cum Fructu, known as Kōjin in Japanese) were used as a hangover remedy and liver tonic.

Korean traditional medicine (Hanbang) records use of the fruit and seeds under the name Jigugu (枳椇), with similar indications.

What Traditional Use Actually Validates (And Doesn’t)

Traditional use is a population-level safety signal, not a clinical trial. Centuries of human consumption without documented toxicity in traditional medicine populations tells us something meaningful about the safety profile — but not the specific mechanism or dose.

What the historical record does:

Establishes a safety baseline going back 1,000+ years
Identifies the biological target (alcohol effects, liver) correctly — before anyone knew about ADH, ALDH, or GABA-A receptors
Provides ethnopharmacological starting point that directed modern research

What it doesn’t do:

Prove the specific mechanisms DHM uses (those required modern pharmacology)
Establish optimal doses (traditional use involved consuming the whole fruit/peduncle, not isolated DHM)
Replace clinical evidence (which exists and is stronger)

The honest framing: traditional use is contextual support, not the primary evidence. DHM’s case rests on the modern research. The traditional history is interesting and adds credibility, but it’s the 2026 MASLD RCT and the 2012 UCLA Journal of Neuroscience study that matter most.

How DHM Was Isolated

The isolation and characterization of dihydromyricetin from Hovenia dulcis was accomplished through 20th century phytochemical research. Chinese and Japanese researchers identified the flavonoid fraction of the plant extract responsible for its hepatoprotective effects, with DHM emerging as the primary bioactive compound.

The name “dihydromyricetin” reflects its chemical structure — a dihydro (partially reduced) form of myricetin, a common dietary flavonoid. “Hovenia dulcis” as a supplement brand name is derived directly from the plant’s Latin genus name, connecting the modern product to its botanical origin.

The Gap Between Traditional Use and Modern Research

Traditional medicine identified the right target — alcohol and liver health — but had no mechanism. Modern research identified the mechanisms — GABA-A modulation, ADH/ALDH upregulation, antioxidant activity, senolytic via PRDX2 — but had no thousand-year safety history.

The 2026 MASLD RCT closed the loop: 12 months of daily use in a liver disease population with zero adverse events. The mechanistic research explains why traditional practitioners were right about what it does. The clinical trial confirms it does it safely in modern populations.

This convergence — traditional use pointing the right direction, modern science explaining the mechanism, clinical trials confirming safety — is the pattern that separates credible plant-derived supplements from marketing fiction.

→ What Is DHM? Complete Guide → → DHM Safety Profile → → 2026 MASLD RCT →